"Hepatitis B Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
Descriptor ID |
D006510
|
MeSH Number(s) |
D12.776.124.486.485.114.254.450.504 D12.776.124.790.651.114.254.450.504 D12.776.377.715.548.114.254.450.504
|
Concept/Terms |
Hepatitis B Antibodies- Hepatitis B Antibodies
- Antibodies, Hepatitis B
- B Antibodies, Hepatitis
- Anti-Australia Antigens
- Anti Australia Antigens
- Antigens, Anti-Australia
- Anti-Hepatitis B Antigens
- Anti Hepatitis B Antigens
- Antigens, Anti-Hepatitis B
- B Antigens, Anti-Hepatitis
- Hepatitis B Virus Antibodies
- Anti HBAg
- HBAg, Anti
- Anti-HBAg
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B Antibodies".
This graph shows the total number of publications written about "Hepatitis B Antibodies" by people in this website by year, and whether "Hepatitis B Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 1 | 1 | 2 |
2000 | 0 | 2 | 2 |
2001 | 1 | 0 | 1 |
2002 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2011 | 0 | 1 | 1 |
2012 | 0 | 3 | 3 |
2013 | 1 | 2 | 3 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
2021 | 0 | 2 | 2 |
2022 | 0 | 1 | 1 |
2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B Antibodies" by people in Profiles.
-
Investigation of the frequencies of various B cell populations in non-responder healthcare workers in comparison with responders to hepatitis B virus vaccination. Trans R Soc Trop Med Hyg. 2023 09 01; 117(9):628-636.
-
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors. Clin Lymphoma Myeloma Leuk. 2023 08; 23(8):610-615.
-
False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385.
-
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int. 2023 04; 17(2):509-511.
-
Hepatitis B and Health Care Workers. Clin Liver Dis. 2021 11; 25(4):859-874.
-
Hepatitis B virus antibody status provides new insights in diffuse large B-Cell lymphoma. Leuk Lymphoma. 2021 06; 62(6):1281-1283.
-
Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy. Inflamm Bowel Dis. 2018 01 18; 24(2):380-386.
-
Impact of "a" determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B. J Med Virol. 2017 10; 89(10):1796-1803.
-
Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):772-778.
-
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Apr; 23(4):581-587.